BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 38527526)

  • 1. Association between antiviral treatments and fracture in elderly patients with HBV needs further evaluation.
    Wu JL; Luo JY; Jiang ZB
    J Hepatol; 2024 Mar; ():. PubMed ID: 38527526
    [No Abstract]   [Full Text] [Related]  

  • 2. Reply to: "Association between antiviral treatments and fracture in elderly patients with HBV needs further evaluation".
    Lai JC; Yip TC; Wong GL
    J Hepatol; 2024 May; ():. PubMed ID: 38763357
    [No Abstract]   [Full Text] [Related]  

  • 3. Antiviral Treatments Eliminate the Adverse Impacts of High Baseline HBV Loads on the Survival of HBV-Related HCC Patients.
    Hu Z; Sun X; Mei J; Hu Z; Yang Z; Hou J; Fu Y; Wang X; Chen M
    J Hepatocell Carcinoma; 2022; 9():315-325. PubMed ID: 35469289
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of chronic hepatitis B virus infection - Dutch national guidelines.
    Buster EH; van Erpecum KJ; Schalm SW; Zaaijer HL; Brouwer JT; Gelderblom HC; de Knegt RJ; Minke Bakker C; Reesink HW; Janssen HL;
    Neth J Med; 2008; 66(7):292-306. PubMed ID: 18663260
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Post-infection viral superinfection technology could treat HBV and HCV patients with unmet needs.
    Bakacs T; Safadi R; Kovesdi I
    Hepatol Med Policy; 2018; 3():2. PubMed ID: 30288325
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of HBV DNA replication with antiviral treatment outcomes in the patients with early-stage HBV-related hepatocellular carcinoma undergoing curative resection.
    Chen JL; Lin XJ; Zhou Q; Shi M; Li SP; Lao XM
    Chin J Cancer; 2016 Mar; 35():28. PubMed ID: 26992891
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of Hepatitis B virus infection on postoperative complications and length of stay in elderly patients with hip fracture: A retrospective cohort study.
    Cheng T; Li G; Mao X; Hao L; Cheng X; Ning H
    Injury; 2023 Jul; 54(7):110812. PubMed ID: 37198044
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Impact of Antiviral Treatment of Hepatitis B Virus after Kidney Transplant and the Latest Insights.
    Fabrizi F; Donato MF; Tripodi F; Regalia A; Lampertico P; Castellano G
    Pathogens; 2023 Feb; 12(2):. PubMed ID: 36839612
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Self-motivated medical care-seeking behaviors and disease progression in a community-based cohort of chronic hepatitis B virus-infected patients in China.
    Zheng H; Zhang G; Wang F; Yin Z; Miao N; Sun X; Liang X; Cui F
    BMC Public Health; 2019 Jul; 19(1):901. PubMed ID: 31286924
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiviral prophylaxis during chemotherapy or immunosuppressive drug therapy to prevent HBV reactivation in patients with resolved HBV infection: a systematic review and meta-analysis.
    Su YC; Lin PC; Yu HC; Wu CC
    Eur J Clin Pharmacol; 2018 Sep; 74(9):1111-1119. PubMed ID: 29845351
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of Hepatitis B Virus DNA Level and Follow-up Interval With Hepatocellular Carcinoma Recurrence.
    Wang W; Tian SL; Wang H; Shao CC; Wang YZ; Li YL
    JAMA Netw Open; 2020 Apr; 3(4):e203707. PubMed ID: 32338753
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Successful withdrawal of antiviral treatment in kidney transplant recipients with chronic hepatitis B viral infection.
    Cho JH; Lim JH; Park GY; Kim JS; Kang YJ; Kwon O; Choi JY; Park SH; Kim YL; Kim HK; Huh S; Kim CD
    Transpl Infect Dis; 2014 Apr; 16(2):295-303. PubMed ID: 24628837
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preventing Hepatitis B Reactivation During Anti-CD20 Antibody Treatment in the Veterans Health Administration.
    Jasmine Bullard A; Cunningham FE; Volpp BD; Lowy E; Beste LA; Heron BB; Geraci M; Hammond JM; LaPlant K; Stave EA; Turner MJ; O'Leary MC; Kelley MJ; Hunt CM
    Hepatol Commun; 2018 Sep; 2(9):1136-1146. PubMed ID: 30202826
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of antiviral resistant hepatitis B virus subpopulations in patients with chronic hepatitis B by using terminal restriction fragment length polymorphism.
    Şahin E
    Virusdisease; 2015 Dec; 26(4):267-75. PubMed ID: 26645037
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discontinuation of antiviral prophylaxis correlates with high prevalence of hepatitis B virus (HBV) reactivation in rheumatoid arthritis patients with HBV carrier state: a real-world clinical practice.
    Mo YQ; Liang AQ; Ma JD; Chen LF; Zheng DH; Schumacher HR; Dai L
    BMC Musculoskelet Disord; 2014 Dec; 15():449. PubMed ID: 25532827
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The association of hepatitis B virus screening and antiviral prophylaxis with adverse liver outcomes in Chinese cancer patients undergoing chemotherapy: A retrospective study.
    He LY; Wang YL; Tian X; Chen WQ
    Medicine (Baltimore); 2020 Apr; 99(14):e19647. PubMed ID: 32243396
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current antiviral practice and course of Hepatitis B virus infection in inflammatory arthritis: a multicentric observational study (A + HBV study).
    Kalyoncu U; Emmungil H; Onat AM; Yılmaz S; Kaşifoglu T; Akar S; İnanç N; Yıldız F; Küçükşahin O; Karadağ Ö; Mercan R; Bes C; Yazısız V; Yılmazer B; Özmen M; Erten Ş; Şenel S; Yazıcı A; Taşçılar K; Kalfa M; Kiraz S; Kısacık B; Pehlivan Y; Kılıç L; Şimşek İ; Çefle A; Akkoç N; Direskeneli H; Erken E; Turgay M; Öztürk MA; Soy M; Aksu K; Dinç A; Ertenli İ
    Eur J Rheumatol; 2015 Dec; 2(4):149-154. PubMed ID: 27708953
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiviral activity of Bay 41-4109 on hepatitis B virus in humanized Alb-uPA/SCID mice.
    Brezillon N; Brunelle MN; Massinet H; Giang E; Lamant C; DaSilva L; Berissi S; Belghiti J; Hannoun L; Puerstinger G; Wimmer E; Neyts J; Hantz O; Soussan P; Morosan S; Kremsdorf D
    PLoS One; 2011; 6(12):e25096. PubMed ID: 22162746
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of vitamin D and polymorphisms of its receptor with antiviral therapy in pregnant women with hepatitis B.
    Wang R; Zhu X; Zhang X; Liu H; Ji YL; Chen YH
    World J Gastroenterol; 2023 May; 29(19):3003-3012. PubMed ID: 37274802
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis B reactivation: diagnosis and management.
    Huang SC; Yang HC; Kao JH
    Expert Rev Gastroenterol Hepatol; 2020 Jul; 14(7):565-578. PubMed ID: 32448008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.